245 related articles for article (PubMed ID: 18973993)
1. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice.
Karpova NN; Lindholm J; Pruunsild P; Timmusk T; Castrén E
Eur Neuropsychopharmacol; 2009 Feb; 19(2):97-108. PubMed ID: 18973993
[TBL] [Abstract][Full Text] [Related]
2. Standardised ginseng extract G115® potentiates the antidepressant-like properties of fluoxetine in the forced swim test.
Terstege DJ; MacDonald DS; Tasker RA
Acta Neuropsychiatr; 2021 Jun; 33(3):141-147. PubMed ID: 33478610
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse.
Schroeder FA; Lin CL; Crusio WE; Akbarian S
Biol Psychiatry; 2007 Jul; 62(1):55-64. PubMed ID: 16945350
[TBL] [Abstract][Full Text] [Related]
4. Behavioural outcomes of perinatal maternal fluoxetine treatment.
McAllister BB; Kiryanova V; Dyck RH
Neuroscience; 2012 Dec; 226():356-66. PubMed ID: 23000627
[TBL] [Abstract][Full Text] [Related]
5. Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines.
Koponen E; Rantamäki T; Voikar V; Saarelainen T; MacDonald E; Castrén E
Cell Mol Neurobiol; 2005 Sep; 25(6):973-80. PubMed ID: 16392030
[TBL] [Abstract][Full Text] [Related]
6. Effects of moderate treadmill exercise and fluoxetine on behavioural and cognitive deficits, hypothalamic-pituitary-adrenal axis dysfunction and alternations in hippocampal BDNF and mRNA expression of apoptosis - related proteins in a rat model of post-traumatic stress disorder.
Shafia S; Vafaei AA; Samaei SA; Bandegi AR; Rafiei A; Valadan R; Hosseini-Khah Z; Mohammadkhani R; Rashidy-Pour A
Neurobiol Learn Mem; 2017 Mar; 139():165-178. PubMed ID: 28137660
[TBL] [Abstract][Full Text] [Related]
7. Postnatal exposure to fluoxetine led to cognitive-emotional alterations and decreased parvalbumin positive neurons in the hippocampus of juvenile Wistar rats.
Meurer YDSR; Linhares SSG; Lima ADC; de Aquino ACQ; Brandão LEM; Nôga DA; Campelo CLDC; Lima RH; Cavalcante JS; Engelberth RCGJ; Ribeiro AM; Silva RH
Int J Dev Neurosci; 2021 Nov; 81(7):616-632. PubMed ID: 34196404
[TBL] [Abstract][Full Text] [Related]
8. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Pilar-Cuéllar F; Vidal R; Pazos A
Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
[TBL] [Abstract][Full Text] [Related]
9. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.
Deltheil T; Tanaka K; Reperant C; Hen R; David DJ; Gardier AM
Int J Neuropsychopharmacol; 2009 Aug; 12(7):905-15. PubMed ID: 19236729
[TBL] [Abstract][Full Text] [Related]
10. Repeated fluoxetine treatment induces long-lasting neurotrophic changes in the medial prefrontal cortex of adult rats.
Song T; Wu H; Li R; Xu H; Rao X; Gao L; Zou Y; Lei H
Behav Brain Res; 2019 Jun; 365():114-124. PubMed ID: 30849415
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.
Li K; Shen S; Ji YT; Li XY; Zhang LS; Wang XD
Neurosci Bull; 2018 Apr; 34(2):303-311. PubMed ID: 29086908
[TBL] [Abstract][Full Text] [Related]
12. Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring.
Boulle F; Pawluski JL; Homberg JR; Machiels B; Kroeze Y; Kumar N; Steinbusch HW; Kenis G; Van den Hove DL
Dev Psychobiol; 2016 May; 58(4):427-38. PubMed ID: 26608001
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
14. Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats.
Maya Vetencourt JF; Tiraboschi E; Spolidoro M; Castrén E; Maffei L
Eur J Neurosci; 2011 Jan; 33(1):49-57. PubMed ID: 21156002
[TBL] [Abstract][Full Text] [Related]
15. Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring.
Boulle F; Pawluski JL; Homberg JR; Machiels B; Kroeze Y; Kumar N; Steinbusch HWM; Kenis G; van den Hove DLA
Horm Behav; 2016 Apr; 80():47-57. PubMed ID: 26844865
[TBL] [Abstract][Full Text] [Related]
16. Effects of adolescent administration of fluoxetine on novel object recognition memory, anxiety-like behaviors, and hippocampal brain-derived neurotrophic factor level.
Sadegzadeh F; Sakhaie N; Dehghany R; Adak O; Saadati H
Life Sci; 2020 Nov; 260():118338. PubMed ID: 32841662
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling.
Ma M; Ren Q; Yang C; Zhang JC; Yao W; Dong C; Ohgi Y; Futamura T; Hashimoto K
Sci Rep; 2016 Dec; 6():39209. PubMed ID: 27991542
[TBL] [Abstract][Full Text] [Related]
18. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
Durkin S; Prendergast A; Harkin A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
[TBL] [Abstract][Full Text] [Related]
19. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.
Norcross M; Mathur P; Enoch AJ; Karlsson RM; Brigman JL; Cameron HA; Harvey-White J; Holmes A
Psychopharmacology (Berl); 2008 Oct; 200(3):413-24. PubMed ID: 18594797
[TBL] [Abstract][Full Text] [Related]
20. BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.
Bath KG; Jing DQ; Dincheva I; Neeb CC; Pattwell SS; Chao MV; Lee FS; Ninan I
Neuropsychopharmacology; 2012 Apr; 37(5):1297-304. PubMed ID: 22218094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]